Medications for Older Persons Recommendations, Harms, Evidence
-
- Taschenbuch
- eBook ausgewählt
-
Form:Einzelkauf Download
-
Sprache:Englisch
153,99 €
inkl. gesetzl. MwSt.Beschreibung
Produktdetails
Format
ePUB 3
Kopierschutz
Nein
Family Sharing
Nein
Text-to-Speech
Ja
Erscheinungsdatum
01.11.2025
Herausgeber
MD ThomasVerlag
Elsevier Science & Techn.Seitenzahl
300 (Printausgabe)
Dateigröße
12423 KB
Sprache
Englisch
EAN
9780443290268
Medications for Older Persons: Recommendations, Harms, Evidence provides a comprehensive resource detailing the benefits of medications for older individuals. It also addresses the potential harms associated with the prescription of potentially inappropriate medications or omissions in prescribing and examines how many adverse events, rehospitalizations, and deaths can be attributed to these medications. The book opens with a summary of medications that most benefit older patients, followed by the impact of older persons' alcohol consumption, self-medication, and medication list accuracy and how these factors correlate to health outcomes.The remainder of the book is devoted to the assessment of medication groups focusing on Numbers Needed to Treat, Numbers Needed to Harm, and characteristics and numbers of adverse events. Medication groups covered include cardiovascular, central nervous system, renal, gastrointestinal, musculoskeletal, respiratory, endocrine, pain, and fall prevention.
- Conveys the benefit and harm profiles of medications for older persons
- Outlines which randomized controlled trials (RCTs) of medication effects have the lowest risk of bias and highest GRADE quality
- Discusses which randomized, controlled trials (RCTs) have the longest and most complete follow up and accounts for the key risk factors and confounders
- Conveys the benefit and harm profiles of medications for older persons
- Outlines which randomized controlled trials (RCTs) of medication effects have the lowest risk of bias and highest GRADE quality
- Discusses which randomized, controlled trials (RCTs) have the longest and most complete follow up and accounts for the key risk factors and confounders
Noch keine Bewertungen vorhanden
Verfassen Sie die erste Bewertung zu diesem Artikel
Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.
Kurze Frage zu unserer Seite
Vielen Dank für Ihr Feedback
Wir nutzen Ihr Feedback, um unsere Produktseiten zu verbessern. Bitte haben Sie Verständnis, dass wir Ihnen keine Rückmeldung geben können. Falls Sie Kontakt mit uns aufnehmen möchten, können Sie sich aber gerne an unseren Kund*innenservice wenden.
zum Kundenservice